Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PODD – Insulet Corporation

Float Short %

2.96

Margin Of Safety %

-1

Put/Call OI Ratio

1.14

EPS Next Q Diff

-0.05

EPS Last/This Y

-1.08

EPS This/Next Y

1.29

Price

279.95

Target Price

377.48

Analyst Recom

1.43

Performance Q

-14.89

Relative Volume

1.9

Beta

1.41

Ticker: PODD




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-26PODD288.541.093.008717
2025-12-29PODD286.481.100.428724
2025-12-30PODD287.031.090.378722
2025-12-31PODD284.181.090.008740
2026-01-02PODD282.881.081.428757
2026-01-05PODD283.471.100.678817
2026-01-06PODD295.171.100.018835
2026-01-07PODD299.171.080.178903
2026-01-08PODD292.881.070.268933
2026-01-09PODD288.991.070.478935
2026-01-12PODD278.411.070.708952
2026-01-13PODD278.171.051.479050
2026-01-14PODD282.921.050.419055
2026-01-15PODD286.621.049.439016
2026-01-16PODD287.760.980.439300
2026-01-20PODD284.321.150.126151
2026-01-21PODD284.891.140.506175
2026-01-22PODD280.841.140.846192
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-26PODD288.3727.1166.74.89
2025-12-29PODD287.2727.1165.04.89
2025-12-30PODD287.0427.1166.94.89
2025-12-31PODD284.1827.1162.34.89
2026-01-02PODD282.8827.1165.04.89
2026-01-05PODD283.5727.1168.74.89
2026-01-06PODD294.3627.1187.54.89
2026-01-07PODD299.1727.1176.14.89
2026-01-08PODD292.8127.1156.34.89
2026-01-09PODD288.9927.1160.54.89
2026-01-12PODD278.5227.1148.44.89
2026-01-13PODD278.1927.1166.84.89
2026-01-14PODD282.9327.0176.54.89
2026-01-15PODD286.4827.0174.14.89
2026-01-16PODD287.7227.0169.74.89
2026-01-20PODD284.3427.1161.34.89
2026-01-21PODD284.8927.1168.74.89
2026-01-22PODD279.9527.1158.34.89
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-26PODD-2.69-1.132.97
2025-12-29PODD-2.69-1.042.97
2025-12-30PODD-2.69-1.042.97
2025-12-31PODD-2.69-1.042.97
2026-01-02PODD-2.69-1.042.97
2026-01-05PODD-2.69-1.032.97
2026-01-06PODD-2.69-1.032.97
2026-01-07PODD-2.69-1.032.97
2026-01-08PODD-2.69-1.032.97
2026-01-09PODD-2.69-1.032.97
2026-01-12PODD-2.66-0.912.97
2026-01-13PODD-2.69-0.912.96
2026-01-14PODD-2.69-0.912.96
2026-01-15PODD-2.69-0.912.96
2026-01-16PODD-2.69-0.912.96
2026-01-20PODD-2.69-0.142.96
2026-01-21PODD-2.69-0.142.96
2026-01-22PODD-2.69-0.142.96
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

1.24

Avg. EPS Est. Current Quarter

1.46

Avg. EPS Est. Next Quarter

1.19

Insider Transactions

-2.69

Institutional Transactions

-0.14

Beta

1.41

Average Sales Estimate Current Quarter

768

Average Sales Estimate Next Quarter

714

Fair Value

278.23

Quality Score

89

Growth Score

100

Sentiment Score

62

Actual DrawDown %

21.1

Max Drawdown 5-Year %

-61.3

Target Price

377.48

P/E

81.24

Forward P/E

44.96

PEG

1.3

P/S

7.81

P/B

14.23

P/Free Cash Flow

46.5

EPS

3.45

Average EPS Est. Cur. Y​

4.89

EPS Next Y. (Est.)

6.18

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.76

Relative Volume

1.9

Return on Equity vs Sector %

-9.5

Return on Equity vs Industry %

0.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

158.3
Insulet Corporation
Sector: Healthcare
Industry: Medical Devices
Employees: 3900
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
stock quote shares PODD – Insulet Corporation Stock Price stock today
news today PODD – Insulet Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch PODD – Insulet Corporation yahoo finance google finance
stock history PODD – Insulet Corporation invest stock market
stock prices PODD premarket after hours
ticker PODD fair value insiders trading